Publication | Closed Access

The administration of Escherichia coli Nissle 1917 ameliorates irinotecan–induced intestinal barrier dysfunction and gut microbial dysbiosis in mice

DysbiosisMucosal ImmunologyMicrobial PathogensGut MicrobiologyIntestinal Barrier DysfunctionMicrobiologyGut BarrierMicrobiomeIntestinal MicrobiotaMedicineClinical MicrobiologyGut Microbial Dysbiosis